Abstract
Fungal infections, from mild itching to fatal infections, lead to chronic diseases and death. Antifungal agents have incorporated chemical compounds and natural products/phytoconstituents in the management of fungal diseases. In contrast to antibacterial research, novel antifungal drugs have progressed more swiftly because of their mild existence and negligible resistance of infections to antifungal bioactivities. Nanotechnology-based carriers have gained much attention due to their magnificent abilities. Nanoarchitectures have served as excellent carriers/drug delivery systems (DDS) for delivering antifungal drugs with improved antifungal activities, bioavailability, targeted action, and reduced cytotoxicity. This review outlines the different fungal diseases and their treatment strategies involving various nanocarrier-based techniques such as liposomes, transfersomes, ethosomes, transethosomes, niosomes, spanlastics, dendrimers, polymeric nanoparticles, polymer nanocomposites, metallic nanoparticles, carbon nanomaterials, and nanoemulsions, among other nanotechnological approaches.
| Original language | English |
|---|---|
| Article number | e7119 |
| Pages (from-to) | 1-19 |
| Number of pages | 19 |
| Journal | Applied Sciences |
| Volume | 11 |
| Issue number | 15 |
| Early online date | 31 Jul 2021 |
| DOIs | |
| Publication status | Published online - 31 Jul 2021 |
Bibliographical note
Publisher Copyright:© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
Keywords
- antifungal drugs
- drug delivery
- fungal infection
- nanoarchitecture carriers
- Nanoarchitecture carriers
- Drug delivery
- Fungal infection
- Antifungal drugs
